In light of the World Health Organization's guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, this brief provides an analysis of relevant technical, regulatory, manufacturing, procurement, logistical, and training considerations of a customized, marked syringe for delivery of gentamicin.
Corporate author(s): PATH
Publication date: October 2016
531 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- About PATH's work > Strengthening health systems
- Health technologies > Newborn health
- Health technologies > Safe injection
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA